Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 306
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 60
MicroRNAs; their therapeutic and biomarker properties
Shahnam Azizi‐Dargahlou, Marcello Iriti, Mahin Pouresmaeil, et al.
Cellular Molecular and Biomedical Reports (2023) Vol. 3, Iss. 2, pp. 73-88
Open Access | Times Cited: 50
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 14
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Renqing Zhao
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
RNA-based therapeutics for neurological diseases
Karen Anthony
RNA Biology (2022) Vol. 19, Iss. 1, pp. 176-190
Open Access | Times Cited: 54
Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4610-4610
Open Access | Times Cited: 47
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 44
Research progress on the role of extracellular vesicles in neurodegenerative diseases
Zhengzhe Li, Xiaoling Wang, Xiaoxing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 22
microRNA-132 regulates gene expression programs involved in microglial homeostasis
Hannah Walgrave, Amber Penning, Giorgia Tosoni, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106829-106829
Open Access | Times Cited: 21
Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11
miR-96-5p alleviates cerebral ischemia-reperfusion injury in mice by inhibiting pyroptosis via downregulating caspase 1
Fa Jin, Lei Jin, Boyang Wei, et al.
Experimental Neurology (2024) Vol. 374, pp. 114676-114676
Closed Access | Times Cited: 9
The emerging roles of miRNA-mediated autophagy in ovarian cancer
Yamin Ding, Xuan Huang, Tuo Ji, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 9
MicroRNAs and synapse turnover in Alzheimer’s disease
Sarthak Dalal, Jaime Ramirez-Gomez, Bhupender Sharma, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102377-102377
Closed Access | Times Cited: 7
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 20
Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures
Macarena S. Aloi, Katherine E. Prater, Raymond E. A. Sánchez, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5954-5974
Closed Access | Times Cited: 16
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Néha Datta, Charlotte Johnson, Dina Kao, et al.
Pharmacological Research (2023) Vol. 194, pp. 106870-106870
Open Access | Times Cited: 16
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 15
Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 6
The plasma miRNAome in ADNI: Signatures to aid the detection of at‐risk individuals
D. Krüger, Tonatiuh Peña Centeno, Shiwei Liu, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 7479-7494
Open Access | Times Cited: 5
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Daniela Dias, Renato Socodato
Biomedicines (2025) Vol. 13, Iss. 2, pp. 279-279
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review
Mo‐Kyung Sin, Jeffrey L. Dage, Kwangsik Nho, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1070-1070
Open Access
Page 1 - Next Page

Scroll to top